VERONICA THRASHER: Open Payments
NPI 1104460898 · CHARLESTON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$297 in 14 payments from 11 companies in 2025. Trend: 2023 $1,097 · 2024 $0 · 2025 $297
Food & beverage: $297
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $54 |
| Incyte Corporation | 2 | $53 |
| Genentech USA, Inc. | 2 | $41 |
| Amneal Pharmaceuticals LLC | 1 | $29 |
| Lilly USA, LLC | 1 | $21 |
| Azurity Pharmaceuticals, Inc. | 1 | $21 |
| SANOFI-AVENTIS U.S. LLC | 1 | $19 |
| EMD Serono, Inc. | 1 | $18 |
| Melinta Therapeutics, LLC | 1 | $14 |
| PFIZER INC. | 1 | $14 |
Products named: Nubeqa, Venclexta, BREKIYA, JAKAFI, MONJUVI, VERZENIO, DANZITEN, REZUROCK.
Industry payments across SC — which companies pay providers there.
